Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.80
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 55.80
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Overview from QuotedData

1 Dec 2023 10:59

RNS Number : 4138V
Geiger Counter Ltd
01 December 2023
 

 

Geiger Counter Limited - Annual Overview from QuotedData

1st December 2023

Powered up for growth

Geiger Counter (GCL), which invests in companies involved in the exploration, development and production of uranium, is set to benefit from nuclear power's colossal role in decarbonising the global electricity supply. Governments around the world are making nuclear energy (the only source of zero carbon baseload power - the minimum amount of electric power needed to be supplied to the electrical grid at any given time) a cornerstone of the green agenda. 

Existing nuclear reactors' lives are being extended, while Asia drives a global fleet expansion as demand for uranium surges. Meanwhile, a 10-year bear market has restricted investment in any new supply and created a highly supportive backdrop for uranium, with the spot price jumping considerably in recent months. 

At less than 10% of the overall cost of power production, there is little to no demand destruction from higher pricing, which is why GCL's managers believe that there is material further upside to come. GCL's 19.9% discount to net asset value (NAV) seems both unjustified and extremely attractive.

Full Research:

https://quoteddata.com/research/geiger-counter-limited-powered-growth-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Geiger Counter Limited and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAEAFESKDFFA
Date   Source Headline
30th Nov 202312:45 pmRNSNet Asset Value(s)
30th Nov 202312:15 pmRNSShare Buyback
29th Nov 20232:15 pmRNSNet Asset Value(s)
29th Nov 202310:45 amRNSShare Buyback
28th Nov 20234:40 pmRNSNet Asset Value(s)
27th Nov 20233:15 pmRNSNet Asset Value(s)
24th Nov 202312:10 pmRNSNet Asset Value(s)
24th Nov 20239:30 amRNSMonthly Investor Report
23rd Nov 20233:10 pmRNSNet Asset Value(s)
22nd Nov 20231:15 pmRNSNet Asset Value(s)
21st Nov 20231:00 pmRNSNet Asset Value(s)
20th Nov 20232:30 pmRNSNet Asset Value(s)
17th Nov 20232:15 pmRNSNet Asset Value(s)
16th Nov 20233:00 pmRNSNet Asset Value(s)
15th Nov 20235:15 pmRNSInvestment Manager Acquisition
15th Nov 20232:40 pmRNSNet Asset Value(s)
14th Nov 202311:50 amRNSNet Asset Value(s)
13th Nov 202312:40 pmRNSNet Asset Value(s)
10th Nov 20232:40 pmRNSNet Asset Value(s)
9th Nov 202312:15 pmRNSNet Asset Value(s)
8th Nov 20232:25 pmRNSNet Asset Value(s)
7th Nov 20231:10 pmRNSNet Asset Value(s)
6th Nov 20233:10 pmRNSNet Asset Value(s)
3rd Nov 20233:40 pmRNSNet Asset Value(s)
2nd Nov 20234:00 pmRNSNet Asset Value(s)
1st Nov 20231:35 pmRNSNet Asset Value(s)
31st Oct 20232:30 pmRNSNet Asset Value(s)
30th Oct 20231:00 pmRNSNet Asset Value(s)
27th Oct 20232:55 pmRNSNet Asset Value(s)
26th Oct 202312:45 pmRNSNet Asset Value(s)
25th Oct 20234:45 pmRNSNet Asset Value(s)
24th Oct 20232:35 pmRNSNet Asset Value(s)
23rd Oct 20234:45 pmRNSNet Asset Value(s)
23rd Oct 20232:15 pmRNSShare Buyback
20th Oct 20233:35 pmRNSNet Asset Value(s)
20th Oct 20231:20 pmRNSShare BuyBack
19th Oct 20231:55 pmRNSNet Asset Value(s)
19th Oct 202311:45 amRNSShare BuyBack
18th Oct 20232:35 pmRNSNet Asset Value(s)
18th Oct 202310:45 amRNSShare BuyBack
17th Oct 20233:20 pmRNSNet Asset Value(s)
17th Oct 202311:10 amRNSShare BuyBack
16th Oct 20233:35 pmRNSNet Asset Value(s)
16th Oct 202311:40 amRNSShare Buyback
13th Oct 20234:00 pmRNSNet Asset Value(s)
13th Oct 202310:30 amRNSShare Buyback
12th Oct 20234:40 pmRNSNet Asset Value(s)
11th Oct 20234:30 pmRNSNet Asset Value(s)
11th Oct 20231:00 pmRNSShare Buyback
10th Oct 20233:10 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.